Prehospital Recognition and Identification of Unspecific Symptoms

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03089359

Acronym

PRIUS

Enrollment

414

Registered

2017-03-24

Start date

2015-05-04

Completion date

2021-03-23

Last updated

2021-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morality, Serious Condition

Keywords

Unspecific symptoms, Soluvent urokinase plasminogen activator receptor, Lactate, Emergency Medical Services

Brief summary

This study evaluates the predictive value of soluvent urokinase plasminogen activator receptor (suPAR) and lactate with respect to serious conditions among patients presenting to the EMS with unspecific symptoms.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Unspecific symptoms (not feeling well, decreased general health condition, unable to cope with usual daily activities, feeling weak) * Normal vital signs * Transported to ED * Able to give informed consent/ Next of kin gives informed consent

Exclusion criteria

* Specific symptoms * under 18 years of age * Stays home / other caregiver than ED * Referral from caregiver * No personal numer (social security number)

Design outcomes

Primary

Measure	Time frame	Description
Serious condition	During medical care event	Predefined serious condition

Secondary

Measure	Time frame	Description
Mortality	24hours and 30 days	24h and 30 day mortality

Countries

Finland, Sweden

Outcome results